Latest Headlines
- FDA Grants Accelerated Approval to Tovorafenib for Patients With Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma
- Income Affects Incidence, Outcomes for U.S. Patients With Cervical Cancer
- FDA Approves Nogapendekin Alfa Inbakicept-Pmln for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer
- FDA Approves Alectinib as Adjuvant Treatment for ALK-Positive Non-Small Cell Lung Cancer
48th Annual ONS Congress® Newsreels
- Oncology Nurses Help Patient Find Her Music Again December 22, 2023
- Attendees Leave ONS Congress® and Prepare to Transform Cancer Care April 30, 2023
- Foundation Doubled Its Fundraising Totals at 48th Annual ONS Congress® April 30, 2023
- Thank You, ONS Congress® Attendees! April 30, 2023
- Viva Fiesta With the Local Chapter at ONS Congress® in San Antonio, TX April 29, 2023